Literature DB >> 27956462

Evaluation of neovascularization patterns in an orthotopic rat glioma model with dynamic contrast-enhanced MRI.

Du Xuesong1, Xue Wei1, Liu Heng1, Chen Xiao1, Wang Shunan1, Guo Yu1, Zhang Weiguo1,2.   

Abstract

Background Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has been proved useful in evaluating glioma angiogenesis, but the utility in evaluating neovascularization patterns has not been reported. Purpose To evaluate in vivo real-time glioma neovascularization patterns by measuring glioma perfusion quantitatively using DCE-MRI. Material and Methods Thirty Sprague-Dawley rats were used to establish C6 orthotopic glioma model and underwent MRI and pathology detections. As MRI and pathology were performed at six time points (i.e. 4, 8, 12, 16, 20, and 24 days) post transplantation, neovascularization patterns were evaluated via DCE-MRI. Results Four neovascularization patterns were observed in glioma tissues. Sprout angiogenesis and intussusceptive microvascular growth located inside tumor, while vascular co-option and vascular mimicry were found in the tumor margin and necrotic area, respectively. Sprout angiogenesis and intussusceptive microvascular growth increased with Ktrans, Kep, and Vp inside tumor tissue. In addition, Kep and Vp were positively correlated with sprout angiogenesis and intussusceptive microvascular growth. Vascular co-option was decreased at 12 and 16 days post transplantation and correlated negatively with Ktrans and Kep detected in the glioma margin, respectively. Changes of vascular mimicry showed no significant statistical difference at the six time points. Conclusion Our results indicate that DCE-MRI can evaluate neovascularization patterns in a glioma model. Furthermore, DCE-MRI could be an imaging biomarker for guidance of antiangiogenic treatments in humans in the future.

Entities:  

Keywords:  Glioma; antiangiogenic treatment; dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI); neovascularization; rat

Mesh:

Substances:

Year:  2016        PMID: 27956462     DOI: 10.1177/0284185116681038

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

Review 1.  C6 cell line: the gold standard in glioma research.

Authors:  D Giakoumettis; A Kritis; N Foroglou
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

2.  Aberrant glioblastoma neovascularization patterns and their correlation with DCE-MRI-derived parameters following temozolomide and bevacizumab treatment.

Authors:  Wei Xue; Xuesong Du; Hao Wu; Heng Liu; Tian Xie; Haipeng Tong; Xiao Chen; Yu Guo; Weiguo Zhang
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

3.  Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment.

Authors:  Dan Xu; Shu-Ting Lu; Yu-Shuang Li; Aju Baidya; Hao Mei; Yong He; Bo Wu
Journal:  Drug Des Devel Ther       Date:  2018-10-05       Impact factor: 4.162

4.  The Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in the Differentiation of Pseudoprogression and Recurrence of Intracranial Gliomas.

Authors:  Hui Jing; Xuhong Yan; Junjie Li; Danlei Qin; Ning Zhang; Hui Zhang
Journal:  Contrast Media Mol Imaging       Date:  2022-07-22       Impact factor: 3.009

5.  MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment.

Authors:  Jun Yang; Chengde Liao; Yifan Liu; Guangjun Yang; Tengfei Ke; Yingying Ding; Qinqing Li
Journal:  Oncotarget       Date:  2017-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.